Cargando…

The HEARTS app: a clinical tool for cardiovascular risk and hypertension management in primary health care

HEARTS in the Americas is the regional adaptation of the World Health Organization’s Global Hearts Initiative, which will be the model for risk management for cardiovascular disease (CVD) in primary health care in the Region of the Americas by 2025. It has already been implemented in 21 countries an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ordunez, Pedro, Tajer, Carlos, Gaziano, Thomas, Rodriguez, Yenny A., Rosende, Andres, Jaffe, Marc G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Organización Panamericana de la Salud 2022
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959249/ https://www.ncbi.nlm.nih.gov/pubmed/35355690 http://dx.doi.org/10.26633/RPSP.2022.12

Ejemplares similares

Authors’ response to the letter “Concerning The HEARTS app: a clinical tool for cardiovascular risk and hypertension management in primary health care”
por: Ordunez, Pedro, et al.
Publicado: (2022)

La aplicación HEARTS: una herramienta clínica para el manejo del riesgo cardiovascular y la hipertensión en la atención primaria de salud()
por: Ordunez, Pedro, et al.
Publicado: (2022)

Monitoring and evaluation platform for HEARTS in the Americas: improving population-based hypertension control programs in primary health care
por: Prado, Patric, et al.
Publicado: (2022)

HEARTS in the Americas: innovations for improving hypertension and cardiovascular disease risk management in primary care
por: Ordunez, Pedro, et al.
Publicado: (2022)

HEARTS in the Americas clinical pathway. Strengthening the decision support system to improve hypertension and cardiovascular disease risk management in primary care settings
por: Rosende, Andres, et al.
Publicado: (2023)

HEARTS in the Americas appraisal checklist and clinical pathway for comprehensive hypertension management in primary care
por: Rosende, Andres, et al.
Publicado: (2022)

Integrating hypertension and diabetes management in primary health care settings: HEARTS as a tool
por: Flood, David, et al.
Publicado: (2022)

HEARTS en las Américas: innovaciones para mejorar el manejo de la hipertensión y del riesgo cardiovascular en la atención primaria*
por: Ordunez, Pedro, et al.
Publicado: (2022)

Drivers and scorecards to improve hypertension control in primary care practice: Recommendations from the HEARTS in the Americas Innovation Group
por: Brettler, Jeffrey W., et al.
Publicado: (2022)

Concerning “The HEARTS app: a clinical tool for cardiovascular risk and hypertension management in primary health care”
por: Muñoz Laguna, Javier, et al.
Publicado: (2022)

Improving cardiovascular health in primary care in Saint Lucia through the HEARTS Initiative
por: Philbert, Shana Cyr, et al.
Publicado: (2022)

HEARTS in the Americas: a global example of using clinically validated automated blood pressure devices in cardiovascular disease prevention and management in primary health care settings
por: Ordunez, Pedro, et al.
Publicado: (2022)

Micro-Meta App: an interactive tool for collecting microscopy metadata based on community specifications
por: Rigano, Alessandro, et al.
Publicado: (2021)

Improving cardiovascular health with the patient-centered, integrated primary care HEARTS model in Trinidad and Tobago
por: Doon, Rohit, et al.
Publicado: (2022)

Opportunistic Screening for Hypertension and Selected Cardiovascular Risk Factors among Adults Attending a Primary Health Center in Puducherry, India
por: Majumdar, Anindo, et al.
Publicado: (2014)

Developing population-based hypertension control programs
por: Jaffe, Marc G., et al.
Publicado: (2022)

Assessing costs of a hypertension program in primary care: evidence from the HEARTS program in Mexico
por: Chivardi, Carlos, et al.
Publicado: (2022)

Controlling Lipids AIDS in the Prevention of Type 2 Diabetes, Hypertension, and Cardiovascular Diseases
por: Nayak, Shivananda B., et al.
Publicado: (2017)

2021 World Health Organization guideline on pharmacological treatment of hypertension: Policy implications for the region of the Americas
por: Campbell, Norm R.C., et al.
Publicado: (2022)

Impact of Icosapent Ethyl on Cardiovascular Risk Reduction in Patients With Heart Failure in REDUCE‐IT
por: Selvaraj, Senthil, et al.
Publicado: (2022)

Endothelial dysfunction and atherosclerosis in children with irreversible pulmonary hypertension due to congenital heart disease
por: Çiftel, Murat, et al.
Publicado: (2012)

Chile’s public healthcare sector hypertension control rates before and during the pandemic and HEARTS implementation
por: Barake, Francisca, et al.
Publicado: (2022)

Congenital Heart Disease After the Fukushima Nuclear Accident: The Japan Cardiovascular Surgery Database Study
por: Hirata, Yasutaka, et al.
Publicado: (2020)

HEARTS en las Américas: un ejemplo mundial del uso de dispositivos automatizados de medición de la presión arterial validados clínicamente en la prevención y el manejo de las enfermedades cardiovasculares en entornos de atención primaria de salud()
por: Ordunez, Pedro, et al.
Publicado: (2022)

S-adenosylmethionine and S-adenosylhomocysteine levels in the aging brain of APP/PS1 Alzheimer mice
por: Hooijmans, Carlijn R., et al.
Publicado: (2009)

Immigration Status and Sex Differences in Primary Cardiovascular Disease Prevention: A Retrospective Study of 5 Million Adults
por: Vyas, Manav V., et al.
Publicado: (2021)

Usability, inclusivity, and content evaluation of COVID-19 contact tracing apps in the United States
por: Blacklow, Serena O, et al.
Publicado: (2021)

The Severe Respiratory Insufficiency Application (SRI App): a pilot randomised controlled trial
por: Majorski, Daniel Sebastian, et al.
Publicado: (2021)

Primary Care Screening Tool for Polycystic Ovary Syndrome: Step One in the Battle Against Non-Communicable Disease
por: Kalra, Sanjay, et al.
Publicado: (2023)

Use of YouTube to watch health-related videos and participation in online support groups among US adults with heart disease, diabetes, and hypertension
por: Langford, Aisha T, et al.
Publicado: (2022)

Promising peak flow diary compliance with an electronic peak flow meter and linked smartphone app
por: Antalffy, Thomas, et al.
Publicado: (2020)

A pilot project investigating the use of ONCOpatient®—An electronic patient-reported outcomes app for oncology patients
por: Macanovic, Bojan, et al.
Publicado: (2023)

Hypertension and Coronary Heart Disease
por: Cubrilo-Turek, Mirjana
Publicado: (2003)

The FDA MyStudies app: a reusable platform for distributed clinical trials and real-world evidence studies
por: Wyner, Zachary, et al.
Publicado: (2020)

The good, the bad, and the poorly designed: The mobile app stores are not a user-friendly experience for health and medical purposes
por: Aungst, Timothy, et al.
Publicado: (2022)

Hearing screening using the uHear™ smartphone-based app: reproducibility of results from two response modes
por: da Cunha, Marta Luiza Santana, et al.
Publicado: (2023)

Prevalence of pre-diabetes, diabetes, pre-hypertension, and hypertension in children weighing more than normal
por: Phatale, Priti, et al.
Publicado: (2012)

Challenges to electronic clinical quality measurement using third-party platforms in primary care practices: the healthy hearts in the heartland experience
por: Ahmad, Faraz S, et al.
Publicado: (2019)

A Brief Screening Tool for PTSD: Validation of the Korean Version of the Primary Care PTSD Screen for DSM-5 (K-PC-PTSD-5)
por: Jung, Young-Eun, et al.
Publicado: (2018)

Maternal Hypertensive Disorders of Pregnancy and Offspring Risk of Hypertension: A Population-Based Cohort and Sibling Study
por: Kurbasic, Azra, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6pisqejoj15ucvck7j8n05ku4v